News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
741,132 Results
Type
Article (68156)
Company Profile (280)
Press Release (672696)
Section
Business (205221)
Career Advice (3058)
Deals (36137)
Drug Delivery (118)
Drug Development (85638)
Employer Resources (173)
FDA (16781)
Job Trends (15735)
News (353556)
Policy (34559)
Tag
2024 BioCapital Digital (11)
2024 BioForest Digital (7)
2024 BioForest Standard (1)
2024 BioMidwest Digital (4)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (6)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (14)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (4)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (6)
2024 Pharm Country Digital (8)
2024 Pharm Country Standard (6)
2025 Lone Star Bio Digital (3)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2918)
Academic (2)
Accelerated approval (5)
Adcomms (27)
Allergies (87)
Alliances (51729)
ALS (93)
Alzheimer's disease (1477)
Antibody-drug conjugate (ADC) (126)
Approvals (16756)
Artificial intelligence (269)
Autoimmune disease (21)
Automation (14)
Bankruptcy (335)
Best Places to Work (12212)
BIOSECURE Act (21)
Biosimilars (112)
Biotechnology (192)
Bladder cancer (64)
Brain cancer (29)
Breast cancer (265)
Cancer (2119)
Cardiovascular disease (185)
Career advice (2586)
Career pathing (33)
CAR-T (156)
Cell therapy (442)
Cervical cancer (21)
Clinical research (68997)
Collaboration (819)
Compensation (441)
Complete response letters (30)
COVID-19 (2800)
CRISPR (42)
C-suite (231)
Cystic fibrosis (105)
Data (2017)
Decentralized trials (2)
Denatured (35)
Depression (44)
Diabetes (275)
Diagnostics (6662)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (44)
Drug discovery (127)
Drug pricing (111)
Drug shortages (30)
Duchenne muscular dystrophy (91)
Earnings (79243)
Editorial (39)
Employer branding (21)
Employer resources (151)
Events (114682)
Executive appointments (690)
FDA (17953)
Featured Employer (53)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (737)
Gene editing (108)
Generative AI (28)
Gene therapy (314)
GLP-1 (810)
Government (4963)
Grass and pollen (5)
Guidances (48)
Healthcare (20069)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (127)
Indications (27)
Infectious disease (2946)
Inflammatory bowel disease (148)
Inflation Reduction Act (10)
Influenza (53)
Intellectual property (91)
Interviews (580)
IPO (16741)
IRA (45)
Job creations (3997)
Job search strategy (2165)
Kidney cancer (10)
Labor market (29)
Layoffs (523)
Leadership (20)
Legal (8210)
Liver cancer (75)
Lung cancer (312)
Lymphoma (134)
Machine learning (4)
Management (59)
Manufacturing (285)
MASH (66)
Medical device (13788)
Medtech (13793)
Mergers & acquisitions (19915)
Metabolic disorders (711)
Multiple sclerosis (79)
NASH (22)
Neurodegenerative disease (104)
Neuropsychiatric disorders (27)
Neuroscience (2008)
NextGen: Class of 2025 (7157)
Non-profit (4960)
Northern California (2435)
Now hiring (20)
Obesity (383)
Opinion (262)
Ovarian cancer (73)
Pain (87)
Pancreatic cancer (77)
Parkinson's disease (148)
Partnered (21)
Patents (217)
Patient recruitment (100)
Peanut (51)
People (61598)
Pharmaceutical (69)
Pharmacy benefit managers (17)
Phase I (21332)
Phase II (30207)
Phase III (22641)
Pipeline (1086)
Podcasts (101)
Policy (131)
Postmarket research (3061)
Preclinical (9342)
Press Release (70)
Prostate cancer (99)
Psychedelics (36)
Radiopharmaceuticals (262)
Rare diseases (405)
Real estate (6435)
Recruiting (69)
Regulatory (23499)
Reports (40)
Research institute (2606)
Resumes & cover letters (467)
Rett syndrome (4)
RNA editing (4)
RSV (45)
Schizophrenia (72)
Series A (133)
Series B (83)
Service/supplier (9)
Sickle cell disease (57)
Southern California (2135)
Special edition (14)
Spinal muscular atrophy (162)
Sponsored (31)
Startups (3709)
State (1)
Stomach cancer (13)
Supply chain (64)
Tariffs (11)
The Weekly (64)
United States (21799)
Vaccines (751)
Venture capitalists (37)
Webinars (11)
Weight loss (276)
Women's health (33)
Worklife (19)
Date
Today (116)
Last 7 days (758)
Last 30 days (2828)
Last 365 days (34690)
2025 (8662)
2024 (36332)
2023 (40853)
2022 (52106)
2021 (56970)
2020 (55865)
2019 (49441)
2018 (37526)
2017 (34407)
2016 (34444)
2015 (40180)
2014 (33918)
2013 (30058)
2012 (31630)
2011 (31441)
2010 (30425)
Location
Africa (1045)
Alabama (55)
Alaska (7)
Arizona (201)
Arkansas (14)
Asia (43597)
Australia (7686)
California (5608)
Canada (1869)
China (506)
Colorado (255)
Connecticut (273)
Delaware (131)
Europe (100432)
Florida (837)
Georgia (202)
Idaho (62)
Illinois (548)
India (25)
Indiana (298)
Iowa (7)
Japan (143)
Kansas (98)
Kentucky (25)
Louisiana (10)
Maine (63)
Maryland (872)
Massachusetts (4288)
Michigan (220)
Minnesota (359)
Mississippi (2)
Missouri (85)
Montana (30)
Nebraska (25)
Nevada (57)
New Hampshire (62)
New Jersey (1648)
New Mexico (31)
New York (1633)
North Carolina (1011)
North Dakota (7)
Northern California (2435)
Ohio (200)
Oklahoma (15)
Oregon (36)
Pennsylvania (1252)
Puerto Rico (9)
Rhode Island (26)
South America (1376)
South Carolina (18)
South Dakota (1)
Southern California (2135)
Tennessee (95)
Texas (845)
Utah (170)
Virginia (140)
Washington D.C. (59)
Washington State (527)
West Virginia (3)
Wisconsin (54)
741,132 Results for "national institute of diabetes and digestive and kidney diseases niddk".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Enable Biosciences Receives $3M Phase IIB SBIR Award from NIDDK for Advanced T1D Testing Technology
Enable Biosciences Inc. is elated to announce its receipt of a Phase IIB Small Business Innovation Research (SBIR) award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
December 19, 2023
·
2 min read
BioMidwest
Semaglutide Reduced Risk for Major Kidney Disease Events by 24% for Patients with Type 2 Diabetes and Kidney Disease
Findings from the landmark FLOW trial, the first dedicated kidney outcomes trial with a GLP-1 receptor agonist were reported, demonstrating semaglutide significantly reduces the risk of major kidney disease events and cardiovascular outcomes in patients with type 2 diabetes and chronic kidney disease.
June 24, 2024
·
4 min read
Press Releases
FDA approves Ozempic® (semaglutide) as the only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease
January 28, 2025
·
11 min read
Biotech Beach
National Institute of Health to Fund Preclinical Development of Trethera Lead Drug, TRE-515, for Treatment of Crohn’s Disease
Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of cancer and autoimmune diseases, announced today that it was awarded a Small Business Technology Transfer (STTR) grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) division of the National Institute of Health (NIH).
September 25, 2023
·
5 min read
Press Releases
ACC.25: Bayer Presents New Investigational Heart Failure Data and Continued Portfolio Research in Chronic Kidney Disease in Type 2 Diabetes
March 25, 2025
·
8 min read
Press Releases
Anti-Obesity Drugs Benefit Kidney Transplant Recipients with Type 2 Diabetes
March 6, 2025
·
6 min read
Press Releases
Xylyx Bio awarded $2.45M NIH SBIR grant from NIDDK to facilitate development of effective drugs for fibrotic liver disease
September 17, 2024
·
2 min read
Approvals
Novo Expands GLP-1 Dominance With Ozempic Nod for Kidney Disease
The approval continues the trend of GLP-1s expanding into indications outside of diabetes and weight loss.
January 29, 2025
·
2 min read
·
Tristan Manalac
Regulatory
Novo Nordisk Snags Kidney Disease Expansion for Ozempic in Europe
The EMA approved a kidney disease–related label expansion for the blockbuster GLP-1 drug after a study showed reduced risk of death by 20%.
December 12, 2024
·
1 min read
·
Kate Goodwin
Pharm Country
National Kidney Foundation Recognizes March as National Kidney Month
As March approaches, the National Kidney Foundation is gearing up to observe National Kidney Month, a crucial time dedicated to raising awareness about kidney health and chronic kidney disease.
February 29, 2024
·
5 min read
1 of 74,114
Next
